(Q45479766)

14 December 2017

title

Mucosal vaccination with an attenuated maedi-visna virus clone (English)

1 reference

Sigurbjörg Torsteinsdóttir

14 December 2017

1 reference

0 references

Gudmundur Georgsson

5

object named as

Gudmundur Georgsson

1 reference

14 December 2017

Gudmundur Pétursson

1

1 reference

14 December 2017

Sigrídur Matthíasdóttir

2

1 reference

14 December 2017

Vilhjálmur Svansson

3

1 reference

14 December 2017

Valgerdur Andrésdóttir

4

1 reference

14 December 2017

Agnes H Martin

6

1 reference

14 December 2017

Gudrún Agnarsdóttir

7

1 reference

14 December 2017

Eygló Gísladóttir

8

1 reference

14 December 2017

Steinunn Arnadóttir

9

1 reference

14 December 2017

Svava Högnadóttir

10

1 reference

14 December 2017

Stefán Ragnar Jónsson

11

1 reference

14 December 2017

Olafur S Andrésson

12

1 reference

14 December 2017

Sigurbjörg Torsteinsdóttir

13

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

23

1 reference

14 December 2017

issue

24

1 reference

14 December 2017

page(s)

3223-3228

1 reference

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

Isolation of replication-competent molecular clones of visna virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

Pathogenic proviral molecular clone of neurovirulent visna virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

In vivo and in vitro infection with two different molecular clones of visna virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

Intratracheal inoculation as an efficient route of experimental infection with maedi-visna virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

An indirect enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to maedi-visna virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

Selection of antigenic variants in maedi-visna virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

The histopathology of maedi a slow, viral pneumonia of sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

Protective immunity induced by live attenuated simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.074

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.11.074

1 reference

14 December 2017

1 reference